Charity registration nwnber- 1154727 Exeter Leukaemia Fund CIO Annual Report and Financial Statements for the Year Ended 31 March 2024
Exeter Leukaemia Fund CIO Contents (continued) Reference and Administrdtive Details Trustees, Report 2tolO Statement of Trusiees, Resporksibilitie5 Independent ExamineWs Repon 12 Sialement of Financial Activities 13to 14 Balance Sheet 15 Noies to the Financial Ststements 161027
Exeter Leukaemia Fund CIO Reference and Administrative Details Chairman V E S Salomonsen Trustees V E S Salomonsen l M Kenny CFOX J M Hawkins Sscann S R Cooper Senior Management l Leadership M Southwood. Chief Executive OITicer Team CharitN Registr9tion Tr*umber 154727 Principal Office The ELF Offiee Haematology Centre RoK'al Devon & Exeter Hospital Barrack Road Exeter EX? 5DW Independent Exgminer Thompson Jenner LLP Indepcndent Examiner I Colleion Crescent Exeter DeN"on EX? 4DG Solicitors Tozers Solicitors LLP Broadwalk House Southernhay West Barclays Bank PLC 3 Bedford Streei Exeier Dei'on Bankers EXI ILX Saniander UK PLC si High Sireel Exeter Devon EX4 3HE Page I
Exeter Leukaemia Fund CIO Trustees, Report The trusiees present the annual report toeether with the financial statements of the charity for the year ended 31 March 2024. Trustees and officers The trustees and officers serving during the year and since the year end were as follows= Trustees- V E S Salomonsen l M Kenny J M Hawkins Sscann S R Cooper Chairman.. V E S Salomonsen Senior Managemeni l Leadership Team.. M Southwood. Chief Execulive olcer S Peacock. Head of Operations and Finance {re5igned 21 June 2024) Chief Exeeutii'e Oleer'S Statement This year. ELF ha5 focused on deli¥erin? hiJo quality, relevant and impaciful patient services. &s well as continuing to provide support to the NHS Haematology Centre. Our core services include transport lor patients lo and from appointments. accommodaiion in Exeter for patients receiving reatment at the Royal Devon & Exerer Hospithl. financial SLEPPOrt and advice. coun5elling and wellbeing supporL complementhry therapies. and the provision of refreshments ai the Filling Time kiosk on Y3ty' Ward. A¢r05S the year we 5UPPOrted around ?50 patients and families. representing around a quarter of adult patients affected by blood cancer in Devon. We have reviewed all of our service5 to ensure 'e are operating efficiently and safely and introduced methods for colleclino paiieni feedback to infomi the dewelopmeni of our services. We also introduced the ELF Fello.$h1P Pr02ramme. a scheme desioned to suppon the recruiimeni and reieniion of excellcni stsff working in Haemaiolo&N' SeTr'ices. The firsi FellO'ShIP wa5 a'arded to a nurse working on Yartv Ward io undenak"e a master's deJ(y ee in Advanced Praclice Nursing. Our fijndraisino team worked hard io deliver al)ove ihe income thrgei sei ai the sran of the year. We received donations from a ranee of suppor(ers. includino trusts. local business. and indiN'iduals. Volunteers ran and cycled for ELF. rdised moneN' by bucket collections at supemiarkets. completed Sky Dives and organised a range of eentS from cream teas to quiz nigh15. Independent groups raised funds via well-anended events across the year. We also received some siJu ificant donations from individuals remembering loved ones. We did not receitr'e as much income from legac! giving as we have done in past vears. However. we began to encourage future planned givino through an inforniation campaign and M'cre pleased to receii'e 20 pledges from supporters who intend io remember ELF in their Wills. We extended the opening hours of Filling Time. our kiosk offering hot drinks and light refreshments to patients. families and staff on the w'ard. We also recruited three volunieers io help deliver ihe service and provide cover during periods of staff illness or holida). Page 2
Exeter Leukaemia Fund CIO Trustee5' Report (continued) In November 2023. after an in-depth review. TThslees decided io close the ELF charitv shops. Althou?h the shops madc a small profil. an increascd amounl of manageTnent time 'aS required. pushing the retail function towards negative income. Sadly, this resulted in redundancies for four sthff. and affected the charity's turnover. though ultimaiel!. allowed tnanaqemeni more time to focus on increasing income generation through fundraising and expandino charitable services. We coniinue io keep all services under re%"ieM" and seek new opportunilies to improve our support for patients. We look fon4'ard to conlinuing to increase the number of patients M'e serve and expand the services we offer. Molly Southwood Chief Executive olcer Objective5 and actii'itie5 Policie5 and objectii'es The objeciives of ELF. .hICh are ouilined in ihe Consiiiuiion of the CIO dated l January 2014 are= To promote and proiect the phN'sical and mental health of people suffering from leukaemia and related diseases in the South West of Enoland (and particularli, Ihose living in Devon). and their relative5 and loved one5. through ihe provision of financial assisiance. suppon. specialist equipment. education and practical advice. whether to those people or to hospita15. clinics and hospices in Devon and neighbouring counlies. To advance the educaiion of the public in all areas relating io Leuk&emia and related diseases. In setting objectives and planning for activities. the Trusiees and senior managemeni have given due consideration 10 general guidance published bN' the Charity Commission relating to public benefit. including the guidance 'Public benefit- runnino a charit). (PB? Vision, Mission gnd Strglegy Vision We wani everv patient in Devon diagnosed with blood cancer to have the best PQS5ible outcome. Mission Siatemeni ELF'S mission is io creaie an environment where patients and iheir families are supporfed through their leukaemia journe!.. We want lo ensure all blood cancer patients and their families have access to excellent support seTh'ices, from the poini of diagrkQSiS to recovery and beN'ond. Strategy Working with our partners in the NHS. we will design and deliver sector-leading services to offer direct Support to patieTrt5 and support the Haematology Centre at the Royal Devon & Exeter Hospital. which we helped to build. Page 3
F.xcter Leukaemia Fund CIO Trustees, Report (continued) Strategic Objectii'es ELF Strategic Objectii'es 2024125 l. Service Developmeni a. Increase current service delivery b. North DeN'on and sites other than RDE c. W'ellbeine Ser¥"ices 2. Preparing for future gromth a. Marketing and brdnd awareness b. Incotne oenerdtion. in particular legacies and grants 3. New HomelHub search and planning 4. Isolation Room Refurbishmenl Objective I Sen'ice Development Building on success. auditing current reach and extending to new. audiences Our current service portfolio is focused on patients in Exeter. with limiled offers to places further afield. As service users are added io the Clim. we have ihe opportuniN to audit where our current service users are. as well as some demographic infomiaiion. and where the gaps might be. Increase in service delivery. targets based on uplift from 231?4 perforn)ance. i. Transport= 160 different patients driven across the year. ii. Counselling.. 88 referrals. based on 6 session5 per person. Many people don'l use the full six sessions 50 .¢ would c.1(1 to 5uppvn ¢wund 110 pcoplc. iii. Support groups.. 20 patients acros5 M'o groups. iv. Fellowships= We've awarded 3 this vear and would eXcl a similar number. based on I larger award and ? smaller. Paiietti Grants= Support for 24 patIenfamIlies. vi. Complemeniary Therapy= ?80 sessions. though many paiients have Enultiple sessions. so we expeci to support around 150 people wilh ihis service. We are in the process of working with the therapisi. who does noi use IT. to capture patient data in a secure way. vii. Accommodation- Between l O and 20 patien'famIlIes. viii. Filling Time.. 40-50 customers per day. b. Nonh Devon and other sites i. Work with Trusi ieam to understatjd various sites and what happens at each. ii. Arranue visits to Sites io meet with siaff and patients. iii. Promoie services accordinelv and idenlify areas 'here further resource will be needed. Wellbeing Services i. Audit counselling reach and consider audiences who aren t supported by current service provision. li. Build new services in line with evidenced need. Deliverables Improved data retK)ning on services. Actionable understanding of impacl on patients and families. (Q2) C5ear. Tillen Strate for delivering existing services across Devon and Tn1 sites other then RD&E. {Deadline: Q2) Development plan for any gromqh or new services. including resourcing. (Deadline.. Q4) Page 4
Eieter Leukaemia Fund CIO Trustees, Report (continued) Objeetlve 2 - Prepare for future gro*'th Diversifying and sustaining income stream5 The chariiy has relied on large le_2acies io fund operational aciivity. Generally. these have been realised. However. there has noi been a dedicaied legacv fundraiser in the ieam since 2019. and the lack of a laroe legacy in 20231?4 indicaies Ihe need to locus on ihis area. Additionallj. there is no dedicaied markeiing funciion to raise brand a,areneSS. This year. we M'ill focus on improving our recognition locall), and across Devon. and also cultivate legacy giving. We will additionallv develop a grant strategy based on clear cases for support. a. Marketing and brand awareness Invest siaff lime into awareness-rdi5ing locally (Exeter) and across Devon ii. Reinforce messaging about hom. the charity is funded. especially legacy giving iii. Develop tnarketing strategy in linc 'Ith emereing groM1h plans iv. Develop conient based on impact of services on paiienTS b. Income ueneration. in particular legacies and grants CEO io lead on individual philanthropy. legacy cultivation and stewardship ii. CEO and Developmeni Manager (Parnierships) io develop early grant application strategy. including cascs for support and targe iii. Focus on building more lucralive income streams. including third partv and corporate {Development Manager. Comtnunity and Volun(eeringl iv. Seek io appoini a third fundraiser in Q3. to build on high-performing income streams, anivor focus on North Devon. wilh a view to delivering a budger surplus in ?025,'26. Deliverdble5 Written marketin2 slrategry with identified targets and objectives (Deadline.. Q3) Impaci-based conienl creaied {Deadline= Q2) Trust and Grant applicaiion plan {Deadline: QI ) 20 new leuacy pledge5 (Deadline.. Q4) 200/D increase on fvndraising income from 2023124 budget (Deadline: End Q4} Objeetive 3 - New. HomelHub Planning and search for x 5uilable space to deliver Services and run the charity The charit) s activilies and managemeni are currently delivered from serval sites. primarily the RD&E hospital and the Marsh Barton office. Several of the services we provide. particularly e1]being services. cannoi be delivered on our premises. Across the coming vear we will articulale the space we need to provide our services. with room for growryh. and begin to seek appropriate premises. Deliverables Clearly articulated plan for space requirements. with room for growth (Deadline- Q2) Markei research into resource required. corresEK)nding budget prepared (Deadline.. Q3) Search begun for suiiable premises (Deadline: Q41 Objective 4 - Isolation Room Refurbishment Working with the Yarry ieam. we have ideniified the need to repaini and redecorate the side rooms. or isolation rooms. on Ihe ward. Workine with the Trust. we will fijndraise to complete the work5 for each room. to the agreed standard. This objective is reliani on the TrusL and therefore deadlines will be in line wilh the iimescales thev can work to.rds. Page 5
Exeter Leukaemia Fund CIO Trustees, Report (continued) Deliverables (deadlines to be confinned with RDUT team) Work plan in place for each room Fundraising target agreed Funds secured. Current Service Portfolio The serYi¢es Exeter Leukaemia Fund currently offer in relation to the objectives are as follows.. Transport of patienls lo and from hospital Counselling to help patients and families through the challenges of the illness Financial support through our Patient Support Grnni scheme Funds io purchase equipTnenl 10 improve patient treatment and suppon Accommodation near the h05pithI so families can be close to their loved ones Complementarv therapies for patients slaying on Yarry Ward Free refreshments to patien15 and relatives awaiting Day C&se appointments Financial advice through our partnership with the CAB Legal services through our partnership with Dunn & Baker Main activities undertxken to furth¢r the Charity's purposes for the public benefit Services that ELF provided_for_2023124 Exetcr Leukaemia Fund {ELF) has coniinued to rebuild follow'ing ihe global pandemic of COVID-1g. The charity, ha5 been revLe.1ng ihe ways in which services are provided and made changes necessary io ensure econom}', etTicienc)' and effectivene5S. Transport Service The charil!. has ihree dedicaled drivers taking patients to and froTn iheir home to artend medical appointments at the Haemaiology. Centre. In 202J14 the ELF anSport team cotnpleied 1801 passenger journeys. With a total disiance of 46.400 tniles. This service is seen by exiernal agencie5 and partners as one of ELF'S Unique Selling Point (USP) services. Counsellino SerN'ice We appoinied a Counselling Service5 Lead to run the counselling service. which continues to grow. In 2023.Q4 104 patients were reFe¢d to ihe service and a tolal of 456 sessions were delivered. We also offered 5UPPOrt to gmup work led bv the NHS. Accommodation ELF offers financial support io patients requiring holel stays in Exeter due to their treaimeni plans. We are grateful to our partners at Mercure Souihgaie who offer a discounted rate for ELF patients. Filin&Time The ELF kiosk. in the Haematology Centre recepiion. offers snacks and refreshments io patients and their supporters. A limited number of iiems. includine hot drink5. fruit. biscuits and crisps are offered free of charge. though ma). users elect to ofTer a donation. The cafe is run by a member of ELF staff. and supported by volunteer5 during periods ofannual leave or illnes5. Page 6
Exeter Leukaemia Fund CIO Trustees. Rcport (continued) Complemenia Therapies Arotnatherapy massage treatment is provided for patients staying on Yatfy Ward. During the year. the service offered ?3 I patient appointtnenls. Ciiizens Advice Bureau Service During the vear. ELF has continued to provide links lo the CAB service for patients requiring their specific help. The CAB service provides assisthnce in a range of matters includittg emplowinent. housing. debt. benefits advice. In 20? jJ•4 we were pleased to receive UFKlates from the CAB deiailing the support ihey were able io provide. Thanks to their guidance. haematology paiicnts at the RD&E received a range of benefits and grants totalling nearly half a million pounds. . 4a1 Services ELF offers a free will service (o pa(ienis. patients families. volunieers and 5UPPOrters through a partnership with local soliciiors Dunn and Baker. The ser¥'ice includes Ihe MTriine of a standard w'ill and is complelelN' free of charge. The swiich from a previous naiional supplier o(Yers a more localised personal service with a local otTice. Achievements and performonce 2023124 Fundrdising O_bjectives Improve donor retention by improving impaci and siewardship communicalion Develop sustainable income streams. including legacy and regular giving Develop trusts and grdnts siraiegi. io suppon specific projecLS Improve fvndrdising processes to ensure m]muM etTiciency Fundraisin outcomes Throu2h focused effort and an increase in the number of events the team were able to support. income was up on the previous vear. The fi]ndraisino team had su¢¢ess in a number of areas. particularly Third Party giving and events. and corporate giving. Fundraising was supported by 94 volunieers contributing 510.5 hours of support. covering a range of roles such as administration. bucket collections and coordinating collection boxes. Due to increased activity in other areas. Trusts and Grants income was down on previous vears. though we did receive SOTne uenerous donation5 in this area. In order to improve outcomes in the coming vear. the team devoied lime io developing clear cases for suppon and researching grdni-making bodie5. Retail Following a challenging year with high sthff turnover and issues with the shop premises. the Trustees decided in November 2023 to wind down Ihe chariN's retail function. The decision was taken after a comprehensive review of income. possible alternaiives io closure. and the broader naiional picture for retail. The shop closures resulted in four redundancies. which were managed in consulthtion th'iih the charitv's HR consultants. The Exminsier shop closed in March ?024. and the Crediion shop is scheduled for closure in June ?024. Review of activities The Charl s sthff and irusiees invested a significant amouni of time across the )'ear to reviewing process and governance. This necessaTr' and comprehensive piece of work ensures that the charity is in the strongest possible position to grow ihc future. Page 7
Excter Leukaemia Fund CIO Trustees, Report (continued) The outlook is Yerv positive as we see a sirong response from our supporters. and a renewed partnership with Yan!. Ward. We look forward lo M'orking M'ith staff. Trusiees and partners lo increase our service provision to ensure the best possible ouicomes for haematology patients in Devon. Financial review Goingconcem After making appropriate enquiries. the Trusiees have a reasonable expectation that the Chariw has adequate resources io coniinue in operaiional existence for ihe foreseeable future. For ihis reason. Ihev coniinue io adopi the 20ing concem basis in preparing the financial statements. Further details regarding the adoption of the going concem basis can be found in the accounting policies. Reserves olic The Irusiees, lon?_[e strdieoN is to seek reserves excluding propertN' to provide financial stabilitv and the means for the de&elopment of our principal activities. We iniend io Tnaintain our reserve5 at a level which Thould allow an orderl!, 'Ind dO.n of ihe chariTh should thai ever need to be considered. In ihe coming vear we also iniend io use a portion of our reserves io esthblish an invesmieni ponfolio with the aim of using interest realised io contribuie ioM'ards charity running Costs. We intend to use the reserve5 in the following manner- Financial suSlnabI]itV of the charity Establishmeni of an investsneni portfolio Communilv and Hospital Service developmeni As at Ihe Yearnd. ELF ha5 totsl funds available of £659.303 {2023 £71J.227) and unrestricted fi]nds of £628.168 (?02J £687.6581. Structure. governance and managemenl Constitution Exeter Leukaemia Fund is a regislered charity. number 1154727. and is constituted under a Charity Commission Scheme. The ¢harity is governed by its CIO Deed. dated l January 2014 which was amended 19 Januarv 2021 and under (his deed is consiiruied as a Charitable Incorpordted Organisalion (CIOI. The Trusiees meei quanerly. The CIO deed stipulates that the Trustees shall comprise not more than ien. nor less than three persons. The CIO has power io do an)thing which is calculated io further its objects or is conducive or incidentsl to doing so. In particular. the CIO has power lo: borrow money and to charee ihe whole or any part of its propenv as security for ihe rePalen1 of the moneN borrowed. The CIO must comply as appropriaie with sections 124 and 125 of the Charities Act 201 l. if it Wi5hc5 to mortgage land: buy. take on lease or in e.x¢hange. hire or othernise acquire any property and lo maintain and equip it for use: sell. lease or otherwise dispose of all or any part of the property belonging to the CIO. In exercising this power. the CIO must comply a5 appropriate with sections 117 and 119-12J of the Charities Ac( 2011 emplov and remuneraie such stsff as are necessary for carrying out the work of the CIO. The CIO may emploN' or remunerdte a chariTh' Irusiee onlN' to the eiieni ihai it is permilled io do so bN' clause 6 (Benefits and pa)Inents to charit), trustees and connecied persons) and provided it complies with the conditions of that clause: Page 8
Exeter Leukaemia Fund CIO Trustees, Report (continued) deposit or inve51 funds. emplov a professional fund-manager. and arrange for the investment5 or other propert). of the CIO io be held in the name of a nominee. ITr the same manner and subject 10 the same onditions as the trusiees of a trust are pennitted to do bN' the Trustee Act 2000. Membership of the CIO The meTnbers of the CIO shall be its charity trustees for the time being. The only persons eligible to be members of the CIO are its charity. tmsiees. Membership of the CIO cannot be transfeed io anyone else. An). member and charity trustee who ceases io be a charity mistee automaiicallv ceases to be a member of the CIO. b. Methods of appoinunent or election of Trustees The management of the Charity is the responsibility of ihe Trnsiees who are elecied and co-opied under the iernis of the Charit! Commission Scheme. The Trustees are eligible. in committee. lo appoint additional trustees under the tertns of the CIO consiitution. Apart from the first charity trusiees. every Trustee may be appointed for a m&ximum tenn of ihrec. three-vear iernis b!. a resolution passed at properl%" con%'ened meetings of the CIO Trustees. In selecting individuals for appointment as Trusiees. the existino Trusiees must have regard to the skills. kno"ledge and experience needed for the effective adrninistrdtion of the CIO. c. Policie5 adopted for the induction and training of Trustees New tru51ees are selected based on the skills that the), musl complemeni ihe existints Board of Trustees. They mcei with cxis(in? Trust¢¢s and k¢v Member5 of staff to ensure that the!. fccl comfortablc with thc organisation and happN' 10 become part of the team. The charity Trustees will make available io each new charity Trustee. on or before his or her first appointmenl- a) a copy of the current version of this constitution: and b) a copy of the CIO'S Latest Trusiees, Annual Report and statement of accounts. A5 W'ith all staff= "The Trustees of ELF review salaries on an annual basis. normallN' Decembcr.. however. there is no guaraniee of an auiomaiic increase in your paj. a5 a resuli of an), re¥'iew'" Emplo)ee Handbook. Plans for future periods Page 9
Exetsr Leukaemia Fund CIO Trustees, Report (contlnued) The TnCeS wlt I fo¢1 on the TElatiDnship with cl RD & E. swificalty Yary WBrd and the wider baemathlogy 5erv%ce including that in North Ikvon. in Ordcr to proyide help and Sup[ to patsents in the most meanin] way. This relation5kn"p is seen as pafdmount so thai th¢ Imematology 5t¥ff aTE SUPPOrted by the ¢lLafiry And can therefore provid¢ th¢ best £ar¢ for their patients and so thdt ELF can provide support in dItion to ihis care. Th¢ TeS will also encour4g¢ chatity sthff io undert¢ a rryicw of patient Servi ¢0 eJ)sure thry ¥re bping manag¢d effectively arE fit for purtx)se Rnd the changing needs of the p8tienlS. Funds held 25 CtsStodln None rt was approved by the tntsiecs ofthe cl4Tity on...... ... ... . and signed on its behatf by: VES alomo Page 10
Exeter UkaeMia Fund CIO Statement of Trustees, Responsibi]itles The trw*es are responsible for preparing the mJsiet5' report and the financial siaieni¢nts in accordanre with the UniTed Kingdom A¢¢ounting Swidards (Uniicd Ksngdom Gen¢rdlly Accepted Ac¢ounting Practic¢) and appli¢able law and re8ulation& The law applie&bl¢ to charities requires th¢ tru5tces to pr¢pwr Fin¥nciai Swetllents for ¢ach fllwicial year which ve 2 bue and fair view of the stsre of affairs of the charity and of the incoming rcsources and application of resources of the ¢lwity for thai pcriod. In PTep2ring these fuwicial sw¢ments, the trusice5 are required Ki: select suitable accounling policies and apply then) ¢onsis(enlly' observe the m¢tht¥ts principles in the Charities SORP. mak¢ judgemcnts attd estimatrs that are reasonablc and prudeni ststr whethcr applEcable accounting have b¢¢n followe& subject to any materia] departures dwloscd and explained in the fttlanciai stsremeors: and prepare the fiThancial stat¢¢llts on the goin basis UDl¢ss il is inappmpriate (o pr&sumc tliai the charity will contrT¢ in bu5inw. The tru51ees are responsible for keeping proper accounting recorts that disclose with re&sonabl¢ accuracy ai arty time the f1claI posiiion of th¢ charity ond enable th(m to ensure thc financial statements comply the Charities Act 2011. th¢ Charities {Accowits 8nd Rq)QT(s) Regulations 2(M)8. 2nd the provisions of the consiitutioTL The trustees are a]$0 T¢spoll5iblc for safe8uarth.ng thc akseLS of the chaTiry and hcnce for taking asonable Steps fLFr the prevenrion and detection of fraud and oih¢r irregularities. The trust¢¢s are trsponstl)le for the mainEenance and integrily of the corporate aod financial InforntiOn ineludcd on the cbAritable eompgnys websit¢. L¢8islation governin8 thc preparatsoi) alid di&sctninauon of financial ST4remenrs rnay differ from legislatton in other Jurisdi0$. Approved s of the chgrity on .... Signed on its bchalf by. VESS Chairman Pagell
Exeter Leukacmia Fund CIO Independent Examiner's Report to the trustees of Exeter Leukaemia Fund CIO I report to the tStee5 on mv examination of the accounts of Exeter Leukaemia Fund CIO for the year ended 31 March 2024. Responsibilities and basis of report As the charits. Irusiees of Exeter Leukaemia Fund CIO you are respoftsible for the preparation of the accounts in accordance with ihe requirements of ihe Charities Act 2011 ('the Act,). I repon in respeci of my examinaiion of the Exeier Leukaemia Fund CIO'S accounts carried oui under section 145 of the 201 l Act and in caryino out mv examinalion I have follo.ed all the applicable Directions given by Ihe CharitK. Commission under section 145{5Mb) of the Act. Independent examiner's st8tem¢nt Sincc Exeter Leukaemia Fund CIO'S gross income exceeded £250.000 your examiner must be a member of a bodN' listed in section 145 of the 2011 Aci. I confirni that l am qualified to undertake the examination because I am a member of The Association of Chartered Certified Accountants. which is one of the listed bodies. I have Compleled mv examination. I confirn) thai no maierial matters have come to my attention in connection with the examination giving me Cause lo believe that in any maierial re5peci= accountin? records were noi kept in respeci of Exeier Leukaernia Fund CIO as required by section 130 of the Act: or 2. the accounts do noi accord with those records: or 3. the accounts do noi comply with the accouniing requirements concerning the fonn and content of accounts set out in the Charities (Accounts and Repons) Regulations ?008 other than any requiremeni thai the accounts give a 'true and fair view, which is not a maner considered as part of an independeni examination. I have no concerns and have come across no other matters in connection with the examinaiion io which anention should be drawn in this report in order io enable a proper understhnding of the accounts to be reached. Dave Tucker FCCA Independent Examiner The Association of Chanered Certified Accountants Thompson Jenner LLP Chartered Accountants I Colleton Crescent Exeter Devon EX2 4DG Dale.. .%. i .Np4ernW £cz Page 12
Exeter Leukaemia Fund CIO Statement of Financial Actii'ities for the l'ear Ended 31 March 2024 Unreslrieled runds Rcslricled funds T(btal ?024 Note Income ond Endowments from: Donaiions and legacies (hher irading activities Investment income ?47.133 162.555 32.104 279.237 162.555 9.421 Total income 419.109 451 ?13 Expenditure on: Raising fi]nds Charitable activities {?$0.527) {*41.717) 1250.527) •68.305) (26.588) Total expenditure {49? ?44) (?6.588) 1518.8i2) Net (expenditurellincome 173.135) 5.516 {67.619) Net movement in funds (73.135) 5.516 {67.619) Reconciliglion of funds Total funds brought fonvtrd 687.658 25.619 713.277 Total fi]nds carried forward 20 614.5?3 31.135 645,658 The notes on pages 16 to 27 forTn an integrdl part of these financial statements. Page 13
Exeter Leukaemia Fund CIO Statemenl of Financial Actii'ities for the Year Ended 31 March 2024 {ciTrntinucd) Lnre5trieted funds Restricted funds Total 2023 Note Income and Endow'ments from: Donations and legacies Other trading aciivities Investment income 294.139 137.522 i.909 24.951 319.090 137.522 Total income 435.570 460.5?1 Expenditure on: Raising funds Chariiable aciiviiies 1709.785) 745.777) 1209.785) {249.JOO) (3.5?3) Tolal expenditure {455.562) (3.52Jl {459.085) Net (expenditure).'income 119.99?) )1.428 1.436 Net movement in funds (19.992) 1.436 Reconeiligtion of funds Total funds brouJt forward 707.650 4.191 711.841 Total funds carried fonyard 20 687.658 )5.619 71J ?77 All of the charity's activities derive from continuing operntions durin? the above two periods. The funds breakdown for 2023 is showTr in note 20. The notes on pages 16 to 27 fom) an iniegrdl part of these financial SleMents. Page 14
Exetsr Leukaemia Fund CIO (Registration Dumber: 1154727) Balance Sheet as at 31 March 2024 21124 2023 Nott Flxed Sets Tan8ibl¢ 055ets 13 17,924 16.974 Current a$y¢ts Stocks Deb¢or5 Cash at bank in hand 14 2.627 41475 625.772 3.759 17,755 681,840 15 16 670,874 70J.354 CreditOf5: fallimg due Ivlthln one year 17 (43.140) 17,051) Net Current assets 627.734 696.303 i et %%sets 645.658 713277 Funds of the th*r5ty: R¢stri¢ted Income fund5 Restricied fiJn(Ls' 20 31.135 25.619 Unrestricted incoll funds Unrcstricted fijnds 614,523 687,658 Total lllnds 645.658 713,277 iLt Thc fInan¢i sralmnts on pagcs 16 to 30 approve4J by thc ond authoriscd for issue on ...... ...... ..... and Slyed on th haif by.. VESSa Chairniall an SE The notes on pages 16 to 27 forn an integral pan of these financial statements. Page 15
Eieter Leukaemia Fund CIO 'otes to the Financial Statements for the l'ear Ended 31 .March 2024 Charitv status The charity is a Charitable Incorporated Organisation regisiered in England and Wales. The address of its registered oiTi¢e is= The ELF OtTice HaemalologN Cenre Ro)'al Devon & Eieter Hospithl Exeier EX2 5DW 2 Accounting policies Statemenl of complianee The financial staiements have been prepared IT7 accordance H'ith Aceountin? and Reporting by Charities= Statement of Recommended Praciice (applicable lo Chariiies preparing their accounts in accordance with ihe Financial ReportinLT Standard applicable in ihe UK and Republic of Ircland (FRS 1021) (issued in October 2019) Ichariiies SORP (FRS 102)). the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS I O?) and the Charities Act 2011. Basis of preparation Exeier Leukaemia Fund CIO meets ihe definition of a public benefii entitv under FRS 102. The accounts (financial siaiementsl have been prepared under the historical cosi convention with item5 recogni5ed at cost or transaction value unless othen¥ise sthied in the relevant noie{s) to ihese accounts. Going concern The trustees consider that there are no material uncertainties about the charity's abilit! lo continue as a going concern. Income and endowmen15 Voluntar), income includino donations. 2ifts. leeacies and grants thai provide core funding or are of a general nature 15 recognised when the charifv h&8 entiilemeni io the income. it is probable that the income will be received and (he amouni can be measured with suificieni reliability. Donaiion5 and legacies Donations are recognised when the charity has been notified in TIting of both the amount and Settlement date. In the eveni that a donation is subject to conditions that require a level of perfomiat)ce b). the charity before the charity is entitled io the funds. the income 15 defcrred and not recogni5ed until either those conditions are fully met. or the fulfilmen( of those conditions is u.holly within ihe control of ihe charity. and il is probable thai these conditions will be fulfilled in the reporting period. Legacv gifts are recognised on a case by case basis followin? the grnni of probate when the administrator.lexecutor for the estate ha5 communicated in MTiting both the amouni and sertlemeni dale. In the eveni ihai the gift is in ihe forni of an asset other than cash or a financial asset traded on a recognised stock exchange. recognition is subjeci io the fvalue of the gift being reliably measurable with a degree of reasonable accurac. arkd the title to the asset havin2 been transferred io the charit%'. Page 16
Exeter Leukaemia Fund CIO Notes to the Financial Statements for the Year Ended 31 Nlarch 2024 (continued) Granis receivable Granis are reco£nised when the charitv has an entitlement to the funds and anv condition5 linked io the grants have been met. Where perfonnance conditions are allached 10 the grant and are vei 10 be mei, the income is recognised as a liabiliry and inclLEded on the balance sheet as deferred income to be released. Gifls in k'ind Gifts in kind donated for distribution are included ai valuaiion and recognised &8 income when they are distributed io the projects. GifLs donaied for resale are included as income when the). are sold. Gifl uid Income tai recoverable in relation to donaiions received under gift aid or deeds of covenant is recognised at the titne of the donation. Inveslmenl income Inieresi on fid$ held on deposit is included when receivable and the amount can be measured reliably by the charity- this is normall J. upon noiificaiion of ihe inieresi paid or pavable by (he bank.Dividends are recognised once thc dividend has beeti declared and noiificaiion has been recei%ed of the dividend due. Expenditure All expenditure is recognised once there 15 a legal or construciive obligation to that expcnditurc. il is probable settlemenl is required and ihe amoun( can be measured reliabl¥. All costs are allocaied io the applicable eipendiiure heading thai are0ate similar c051s to that category. W'here costs cannot be directly attributed to particular headings they have been allocaied on a basis consisieni M'iih the use of resources. 1th Cenal staff costs allocaied on the basis of time spenL and deprecialion charges allocated on the portion of the asset's use. Other support costs are allocated based on the sprcad of staff costs. Raisingfunds These are costs incurred in attrdcling voluniary income, the management of investments and those incurred in trading activities thai raise funds. Charilable actlF'ilie Charitable expenditure comprises those costs inCued by the charity in the delivery of its acti11]eS and services for its beneficiaries. It includes boih costs ihai can be allocaied directly to such aciivilies and those costs of an indirect nature necessatTr' io suppon them. Support costs Support costs include Centrdl fimclions and have been allocated to aclivity cost calegories on a basis consisteni with the use of resources. for example. allocating property costs by flr area5. or per ¢apit& staff costs by the time spent and other costs by their usage. GoN'ernance costs "rhese include ihe costs attribulable to the charity's compliance with constitutional and statutory requirements. including audit. strategic management and trustees meelings and reimbursed expenses. Page 17
Eieter Leukacmia Fund CIO Notes to the Financial Stalements for the Year Ended 31 March 2024 (continued) Taxatio The chariti, is considered to pass the tests set out in Paragraph I Schedule 6 of the Finance Act 2010 and therefore it meets the definition of a charitable compan). for UK corpordtion t&K purpose5. Accordingly. the chariTh' is potentially exeTllPi from latiOn in respect of income or capital oains received within categories covered b. Chapter J Part I l of (he Corporation TLX Act ?010 or Section 256 of the Taxation of Charoeable Gains Act 1999 io the exteni that such income or ghins are applied exclusivelv lo charitable purposes. T9ngible fixed a55els Individual fi.xed assets costing £ 100.00 or more are initiall! recorded ai cosL less any subsequent accumulated depreciation and subsequent accumulated impaimlent losses Depreeiation and amorlisglion Depreciaiion is provided on tangible fixed assets so as to write off the cosi or valuation. less any estimated residual value. over their expecied useful economic life &5 follows.. -4sset class Motor vehicles Fixture5 and fittings oirice equipment Depreciation method and rate ?0 /0 strdight line 1511/0 straight line 200/0 and 33.330/0 Straight line Stock tock is valiied at the lower nf cnst and estimated selling price less costs io complete and sell. after due regard for ob501ete and slow moving stocks. Cost is determined usin£ the first-in. first-oui {FIFO). Trade (lebiors Trade dLbtors are amowits due from customers for merchandise sold or rVIceS perforn)ed in the ordinary course of busines5. Trade debtor5 are recognised initiall). ai the transaction price. TheN' are subsequentlv measured at amortised cosi usino the effective inierest meihod. less provision for impairment. A provision for the impaimient of trade debtor5 is esiablished when there is objective evidence that the eharitv will not be able io colleci all amounts due according to the original lemis of the receivables. Cash and cash equil'alents Cash and cash equii'alcnts comprise cash on hand and call deposits. and other shon-lerni highly liquid investments that are readil!, convertible io a known amouni of cash and are subjecl to an insignificant risk of chanoe in value. Trade creditors Trade creditors are obljtialioTts to pav for 200ds or services thal have been acquired in the ordinary course of business from suppliers. Accounts pavable are classified as curretti liabilities if the does not have an unconditional righi. ai the end of the reporting period. to defer sertlemenl of the creditor for at least twelvc month5 after the reportinq da(e. If there is an unconditional riuthi io defer settlemeni for ai le8sl twelve months after the reponing dale. thev are presented as non-current liabilities. Trdde creditors are recognised initially at the trdnsaciion price and subsequently measured at amortised cosi usino the effective interest tnethod. Page 18
Exeter Leukaemia Fund CIO Notes to the Financial Statements for the Year Ended 31 March 2024 (continued) Fund structure UnrestrictLd income funds are general fund5 that are available for use at the trustees discretion in furtherdnce of che objecrives of the charl. Restricted incotne funds are those donated for use in a particular area or for specific purposes. the use of which is resiricied lo that area or purpose. Pensions and other post retirement obligations The charit). operares a delined contribuiion pension herne which is a pension plan under which fixed contributions are paid inlo a pension fund and the charity has no legal or constructive obligation to pav further contributions even if the fund does not hold sufricient assets io pay all employees the benefits relating to emplovee service in the CUent and prior peri(Kls. Contributions to defined contribulion plans are recognised in the Statement of Financial Activities when they are due. If contribution payments exceed the contribution due for service. the excess is reco?nised as a prepa)ent. Financial instruments Thc Charits. onl! ha5 financial assets and financial liabilities of a kind that qualify &5 basic financial InStments. Basic financial instruments are iniliallN' recognised ai transaciion price and subsequently measured at their senlemeni value wilh ihe exception of bank loans which are subsequenily measured at amonised cosi using the effective interest method. Page 19
Exeter Leukaemia Fund CIO Notes to the Financial Statements for the Year F.nded 31 March 2024 (continued) 3 Income from donations and le%acies Unrestricted funds General Resiricted funds Total 2024 Total 2023 Donarions and legacies- Donations from companies. trusts and similar proceeds Legacies Grants, including capital grants- Grants from companies 21 i.9(vl 25.519 20.854 2J4.818 25.519 207.984 92,061 7.650 18.900 19.045 247.133 32.104 279.237 4 Income from other trading activities L.nre51ricted funds General Total funds Total 2023 Trading income- Ch¢irits' 5hop5 Other fundraising 1 ?9.310 1 ?9.3?0 114.805 2?.717 162.555 162.555 l J7.522 5 Investment income Unrestricted funds General Total 2024 Total 2023 Dividends receivable from other listed investments Interest receivable on bank deposits 133 9.288 133 237 3.672 9.4?1 9.421 3.909 Page 20
Tr".xclcr Leuk#L'mia Tr und (.'1() Notes to thL' Financial St#tement% fi)r IhL' Yc'ar b:n(IL.d .11 Miirl'h 2024 {continued} 6 b.xpeiidiliirL' on chxrilahlc Activities C'(Isl ur rai%inx fun(1 'I'inie .4upporl upport C'uunselling -fr#nsporl f¥upport 2024 -fotAI 2023 'folul Si£ifT Los15 l)eprLcialion l()%pilal LquipniLiit Purchases Reni dnd rates Office costs -rravL.l and SLib5iStL'nce 11- and comiiiUI)ILalions RLpairs aiid maiiilLiiaiice .1 r1( n5POrt Profe55ional fees Other Support g>ranls (l)rLTrfill/l.oss on disposal (i()venianLe cosls 129.987 919 14,1470 8,149 64,Y42 2,1192 -i.f .825 1.527 2$3.771 6.gY¥ 183 226,13.3 183 20.447 11.624 32.428 13,123 1.77X 12.1184 2.0021 36.272 19,929 44.528 8.000 7.1 24.486 16.832 27,636 15,234 1,757 7.603 18.407 2,740 19,572 34,024 18,573 4.879 6,388 2,951 579 5.170 53 33 156 2,144 264 77 4?.1 1,06% 531 1.810 75 25.003 3.391 488 19.608 25.003 14,658 45,705 15,049 147 2,709 11,229 20 19 202 384 22.830 7,952 3.208 2.766 5,165 15,049 124 23 44.859 44,85Y 2.32.437 18.090 20,561 18.089 -3.067 1 8.089 23,1.30 18,0¥9 99.1172 18.08Y 108.-f35 (108.535) 518,832 4.59.08.S Supp()rt costs Total expenditure 2024 111.089 250.527 38,6.50 21,156 41,219 50,119 518,832 459.08.5 l olal expenditure 2023 209.785 27.333 37.785 27,36Y 32,574 124,239 459,085 PagiL 21
Eieter Leukaemia Fund CIO Notes to the Financial Statements for the Year Ended 31 March 2024 (continued) Of lolal expenditure £26.588 (2023 - £3.523) is restricted and £492.244 (2023 - £455.562) 15 unrestricted. 7 Anali'sis ofgovernance and support costs Governance costs Llnrestricled funds General Total ?024 Total 2023 Staff costs Wages and salaries Social security COSL8 Pension costs Independeni examiner fees Examinaiion of the financial sthiemen Other fees paid 10 examiners 37.159 3.787 913 37.159 3.787 913 19.122 2.061 468 1.000 2.000 .000 2.000 945 1.890 44.859 44.859 24.486 8 Net incomingloulgoing resources Nei {ouigoing)lincoming resources for the year include-. 2024 2023 {Profit)Iloss on disposal of fixed assets Depreciation of fixed assets 147 6.998 73 5.37? 9 Trustees remuneration and expenses No trustees. nor any persons connecied with them. have received any remunerdtiork from the charity during the year. No trustees have received any reimbursed expenses or any oiher benefits from the charity during the year. Page 22
Exeter Leukaemia Fund CIO Yotes to the Financial Statements for the Year Ended 31 March 2024 (continued) l O Costs 'I'he aggre?aie payroll costs were as follows- 2024 2023 Staff costs during the vear were: Wages and salarics Social securi. cos Pension costs 274.464 16.07? 5.096 229.719 13.528 4.536 ?47.783 The monthly average number of person5 (including senior management / leadership team) employed by the chariN durino the vear was as follows: 2024 2023 Average number of emplovees 14 12 Contributions 10 the employee pension schemes for the year totalled £5.096 (2023 - £4.536). The total employee benefits of the key manaoement personnel of the charity were £83.718 (2023 - £65.061). No employee re¢eived emoluments of more than £60.000 during the vear I I Independent examiner'5 remunergtion 2024 2023 Examinaiion of the financial statements 1.000 945 Other fee5 to exaTniner5 All oiher services 2.000 1.890 12 Taxation The charity is a regisTered charity and is therefore exempi from raxaiion. Page 23
Eieter Leuk#emia Fund CIO Note5 to the Financial Statements for the Year Ended 31 March 2024 (continued) 13 Tangible fixed assets Furniture and equipment Computer equipment Moior Trehicles Total Cost At l Apri5 2023 Additions Disposals 4.483 11.973 18.581 8.095 35.037 8.095 (J,511) At J l March 2024 Depreciation At l April ?023 Charge for the year Eliminated on disposals 3.814 219 3.991 2.395 10.258 4.384 {J.J641 18,063 6,998 {3.J64} At 31 March 20?4 4.033 6.386 Net book value Ai J l March 20?4 450 5.587 11.887 17.924 Ai J l March 2023 669 7.982 8.3?3 16.974 14 Stock 20?4 2023 Stocks 3.759 15 Debtors 2024 2023 Trade debtor5 Prepaj'ments VAT recoverable Other debtors 4.093 8.465 2.565 27.35? 2.597 10,025 1.891 17.755 16 Cash and cash equii'alents 2024 2023 Cash on hand Cash at bank i42 681.498 6?5.499 625.772 681.840 Page 24
F.xeter Leukaemia Fund CIO Notes to the Financial Statements for the Year Ended 31 Marcb 2024 (continued) 17 Creditors: amounts fallin2 due wtthin one !'e2r 2024 2023 Trade creditors Other taxation and social security Other creditors Accruals 9,565 149 950 1.682 4.270 1,377 i2.198 4i.140 7,051 18 Contingent assets Legaev Income As at 31 March 2024. the charity had been notified of one residuary legacy the value of which is uncertain as the exe¢utor 15 awaiting confimation of other claims on the estate. but il is unlikely io exceed £34.?75. As ai the date of approval no further inforn]ation had been received and so this legacy has not been accrued. 19 Ohliggtions under leases and hire purehise contracts Operatine lease Commitments Total future minimum lease payments under non-cancellkble opernting le2ses are as follows". 20?4 2023 Other Within one vear Between one and five years i8.601 19.961 46.955 53.350 58.562 I00.J05 Page 25
Exeter Leukaemia Fund CIO otes to the Financial Statemenls for the Year Ended 31 March 2024 (continued) 20 Funds Balance al .4pril 2023 Incoming resources Re50urce5 expended Balance at 31 Mgrch 2024 Unre51ricted funds General General funds 687.658 419.109 {492 ?44) 614.523 Restricted funds Chei'iihornc Famil). Suite Counsellor Transport Hospital fund Patient support (coordinator) Fellowship 668 668 7,250 10.250 .000 16.729 .000 (3.000) ( 1.000) (5.917) (15.5841 (1.087) 1.830 23.121 12.642 8.537 2.038 Total restricted fund5 25.619 (96.5881 31.135 Total funds 713.277 451,213 (518.832) 645.658 Bal#nee at I April ?0?2 Incoming rt50urce5 Resources eipended Balanceal 31 .March 2023 Unrestricted funds Generul General fimds 707.650 435.570 {455.562) 687.658 Restricted Chei'ithorne Family Suite Coun5ellor Transport Patient Support {Hard5hip Fund) Hospital fund Paiicnl support (coordinator) 873 2.270 48 (205) (2.270) (481 ( 1.000) 668 1.830 ?3.121 1.830 23.121 Total restricted funds 4.191 ?4.951 li.5?3) ?5.619 Total funds 711.841 460.521 (459.085) 713,277 Page 26
Exeter Leukaemia Fund CIO Tlotes to the Financial Statements for the Year Ended 31 March 2024 (continued) The specific purposes for which the funds are io be applied are as follows: Chevithorne Familv Suile The resiricied funds represent amounts received for the Cheviihorne project. The project is complete and Ehe balance caThied fonvard is io pay for the upkeep of the suite. There has not been any spend on thi5 project in ihe l'ear. Counselling - Granis received to cover counselling statTing costs. Trdnspon - Income has been received in the period to help supwyrt the transpon service. Patient Support {Hard5hip Fund) - Donalions of £l.000 received in the previous financial year to help nd paiieni support which was speni in the prior vear. Hospital fund - This fund represents any income received which is resiricied to expenditure on Hospi(al support. Patient Support Coordina(or - This fund represents amounts rni5ed from a campaign thai was run in order to fund the coordinator position. Fellowship - Thi5 fund represents any income received which is res]cted to the fellow'ship proerdmme. 21 Analvsi5 of net gssets between fvnds Unrestricted funds General Total funds at 31 March 2024 Re51ricted funds Taftgible fixed assets Current assets Current liabilities 17.924 639.7J9 {4J.140) 17.924 670.874 {43.140) 31.135 Total nei assets 614.52i 645.658 Unrestricted funds General Total funds at 31 March 2023 Restricted funds Tangible fixed assets Current assets Current liabilities 16.974 677.73$ 17.051) 16.974 70J.354 {7.051) 25.619 Total nei assets 687.658 713.277 22 Related partv transaetions TheiL wL'ie no related pam Msactions in the vear. Page 27